Shearman & Sterling Reps Boston Scientific In £3.3B BTG Buy
Massachusetts-based Boston Scientific Corp., led by Shearman & Sterling LLP, unveiled plans Tuesday to shell out £3.3 billion ($4.2 billion) for U.K.-based BTG PLC, which makes medical devices for the treatment...To view the full article, register now.
Already a subscriber? Click here to view full article